LHLaboratory Corporation of America LH · NYSE
$317.95 -2.19% (-$7.12)
- Market cap
- $26.4B
- Enterprise value
- $33.0B
- P/E
- 26.3x
- Forward P/E
- 17.2x
- PEG
- 1.7x
- P/S
- 1.8x
- P/FCF
- 22.8x
- EV/EBITDA
- 15.3x
- ROIC
- 7.9%
- Gross margin
- 27.8%
- Net margin
- 7.0%
- Dividend yield
- 0.89%
- Payout ratio
- 23.3%
- Net debt/EBITDA
- 3.1x
- Beta
- 0.85
- Free float
- 99.6%
About the company
Laboratory Corporation of America Holdings (LH) is an American company providing diagnostic laboratory services to healthcare organizations, physicians, patients, and pharmaceutical companies. Their portfolio includes a wide range of tests in areas such as hematology, clinical chemistry, pathology, genetics, and microbiology, among others. The company is known for its ability to provide fast and accurate test results, which help physicians in diagnosing and treating various diseases. Laboratory Corporation of America Holdings also invests in research and development of new diagnostic methods and technologies to continuously improve its services and offerings. Laboratory Corporation of America Holdings (LH) shares may be attractive to investors seeking investments in companies operating in the diagnostic laboratory services field with an emphasis on quality, reliability, and innovation.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter
Employees
71,000
Headquarters
Burlington
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number